SPECTA

Denis Lacombe quietly orchestrating the clinical research revolution

Number 68

Cover Story 1 October 2015 0

The scientific complexity and economic cost of developing new cancer therapies demand a level of collaboration and sharing that takes both industry and academia well beyond their comfort zones. EORTC head Denis Lacombe believes he [more]

How Europe can develop better, cheaper cancer drugs

Number 60

Grandround 1 May 2014 0

Modern tools of biological investigation give us opportunities to develop drugs much more efficiently. The president of Europes most important trials organisation explains how these opportunities can and must be exploited to start [more]